Huntington’s disease drug trial helps patient ‘focus on the good’

Huntington’s disease drug trial helps patient ‘focus on the good’

Publication date: Jan 10, 2020

One of the first people in Scotland to take part in a new trial for Huntington’s disease (HD) says the programme has taken him from a -real place of darkness”.

The research, led by Zosia Miedzybrodzka at the University of Aberdeen, aims to find out if a new gene blocking compound can slow progression of the disease.

The 57-year-old said: -Huntington’s disease has had a massive effect on all my family.

Mr Patience travels every two months from his home in Inverness to Aberdeen Royal Infirmary where a sample of his brain fluid is taken for analysis, after which a trial drug or a placebo is administered.

He added: -I’m hoping against hope that I am on the trial drug but even if I’m on the placebo the trial has had a very positive effect on my life.

Concepts Keywords
Aberdeen Articles
Aberdeen Royal Infirmary Genetic code
Antisense Oligonucleotide Deception
Brain Huntingtons
Drug Trial Placebo
Fluid Clinical research
Football
Genetic Code
Hospital
Huntington
Inverness
Memory
Mutant
Patience
Placebo
Scotland
Short Strand
Signalman

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *